Oral administration of Lactobacillus and Bifidobacterium strains of intestinal and vaginal origin to healthy human females: Re-isolation from faeces and vagina

Article English OPEN
Vásquez, Alejandra ; Ahrné, Siv ; Jeppsson, Bengt ; Molin, Göran (2011)
  • Publisher: Microbial Ecology in Health and Disease
  • Journal: Microbial Ecology in Health and Disease (issn: 1651-2235, eissn: 1651-2235)
  • Related identifiers: doi: 10.3402/mehd.v17i1.7811
  • Subject:
    mesheuropmc: food and beverages

The healthy vaginal ecosystem is maintained by the interaction of the vaginal epithelium and the microflora, where lactobacilli and occasionally bifidobacteria play an important role. Imbalances in the dominance of lactobacilli may lead to bacterial vaginosis or yeast vaginitis. Probiotics may be a means to secure a favourable microbial balance in the vagina and, as the normal vaginal flora ascends from the rectal mucosa, a convenient form of administration may be via the oral gastrointestinal route. Ten healthy women of different ages were orally administered a blend of 12 selected Lactobacillus strains and three Bifidobacterium strains originating from the intestine and the vagina. The daily dose of each Lactobacillus strain was 1-3x10<sup>9<sup> CFU and 1x10<sup>8</sup> to 1x10<sup>9</sup> CFU for each Bifidobacterium strain, and the doses were given in an oatmilk/blueberry drink. The treatment went on for 10 days. Samples of faeces and vaginal fluid were taken immediately before the administration was started, after 10 days of administration and 7 days after the termination of the administration. Five strains were recovered from faeces and three from the vagina after treatment. The test strains could be found in 9 of the 10 volunteers. L. plantarum strains, originally isolated from intestinal mucosa, were recovered from the vagina of five subjects after treatment. The L. plantarum strains, together with one strain of L. crispatus and one L. gasseri strain, were recovered from faeces.Key words: Probiotics, Lactobacillus, vagina, oral administration, Bifidobacterium
  • References (29)
    29 references, page 1 of 3

    1. Larsen B. Vaginal flora in health and disease. Clin Obst Gynecol. 1993;36:107 /21.

    2. Redondo-Lopez V, Cook RL, Sobel JD. Emerging role of Lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev Infect Dis. 1990;12:856 /72.

    3. Boris S, Barbe´s C. Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes Infect. 2000;2: 543 /6.

    4. Biswas M. Bacterial vaginosis. Clin Obst Gynecol. 1993;36: 166 /76.

    5. Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan B, et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis. 1999;180:1863 / 8.

    6. Hillier SL, Martius J, Krohn M, Kiviat N, Holmes KK, Eschenbach DA. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med. 1988;319:972 /8.

    7. Pybus V, Onderdonk AB. Microbial interactions in the vaginal ecosystem, with emphasis on the pathogenesis of bacterial vaginosis. Microbes Infect. 1999;1:285 /92.

    8. Boskey ER, Telsch KM, Whaley KJ, Moench TR, Cone RA. Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect Immun. 1999;67:5170 /5.

    9. Famularo G, Pieluigi M, Coccia R, Mastroiacovo P, De Simone C. Microecology, bacterial vaginosis and probiotics: perspectives for bacteriotherapy. Med Hypotheses. 2001;56: 421 /30.

    10. Reid G, Bruce AW. Urogenital infections in women: can probiotics help? Postgrad Med J. 2003;79:428 /32.

  • Metrics
    No metrics available
Share - Bookmark